Methylene Blue Causing Serotonin Syndrome Following Cystocele Repair
Kailash Kapadia1, Felix Cheung2, Wai Lee2
1Stony Brook Medicine, 101 Nicolls Road, Stony Brook, NY 11794, USA.
Abstract:
Methylene blue is an intravenously administered agent that may potentiate serotonin syndrome. The usage of methylene blue to evaluate ureters for injuries and patency during urological surgeries is recognized as common practice. However, there is no mention of serotonin syndrome caused by methylene blue in urological literature or for urological surgery. We report the first urological case in order to raise awareness of the risk for serotonin toxicity with utilizing methylene blue.
Related Concept Videos
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Urologic Endoscopic Procedure: Cystoscopic Examination
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Imaging Studies VI: Voiding Cystourethrography and Cystography
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Drugs Affecting Neurotransmitter Release or Uptake


